Hargroves Thomas Jeffrey 4
4 · Cingulate Inc. · Filed Jun 8, 2026
Research Summary
AI-generated summary of this filing
Cingulate (CING) Director Jeffrey Hargroves Acquires ~97K Shares
What Happened
- Director Jeffrey Hargroves purchased 97,276 common shares of Cingulate at $5.04 each on 2026-02-13 for $490,271 (open market/private purchase). He also acquired 77,821 derivative units at $0.10 each on 2026-02-13 (cost $7,782) and was granted a 15,000‑share derivative award on 2026-03-09 with no cash exercise price reported.
- The cash purchases are buy transactions (a bullish signal insofar as they are insider purchases); the other two items are derivative securities (private‑placement securities and an option/award) rather than immediate sales.
Key Details
- Dates and prices:
- 2026-02-13: 97,276 shares at $5.04 — $490,271 (purchase, code P).
- 2026-02-13: 77,821 derivative units at $0.10 — $7,782 (acquired, derivative; code P).
- 2026-03-09: 15,000 derivative award/options at $0.00 (granted; code A).
- Derivative notes:
- Footnote F2: The common stock and warrants/derivatives were from the issuer’s private placement (Form 8‑K dated Jan 28, 2026).
- Footnote F4: The 15,000‑share option award vests 50% at 6 months and the remainder at 12 months after grant.
- Shares owned after transaction: Not specified in this Form 4; the reporting person’s beneficial ownership has been reported elsewhere per footnote F1.
- Filing timeliness: The initial Form 3 filing was delayed due to EDGAR code issues (footnote F1). This indicates a late filing of initial holdings (transactionTimeliness = 'L').
Context
- These were purchases and awards, not cashless exercises or immediate dispositions—the granted options have vesting, so they are not immediately liquid.
- Derivative acquisitions from a private placement (warrants/options) can carry different economics and dilution than straight stock buys; treat the 77,821 and 15,000 items as non‑immediate common‑share ownership until exercised/vested.
- No speculation on motives: retail investors often view insider purchases as potentially more informative than sales, but consider overall ownership, timing, and company fundamentals.
Insider Transaction Report
Form 4
Cingulate Inc.CING
Hargroves Thomas Jeffrey
Director
Transactions
- Purchase
Common Stock
[F1][F2][F3]2026-02-13$5.04/sh+97,276$490,271→ 97,468 total(indirect: By LLC) - Purchase
Warrant to Purchase Common Stock
[F1][F2][F3]2026-02-13$0.10/sh+77,821$7,782→ 77,821 total(indirect: By LLC)Exercise: $5.04From: 2026-03-24Exp: 2029-03-24→ Common Stock (77,821 underlying) - Award
Stock Option (right to Buy)
[F1][F4]2026-03-09+15,000→ 15,000 totalExercise: $6.85Exp: 2036-03-09→ Common Stock (15,000 underlying)
Footnotes (4)
- [F1]This Form 3 filing was delayed due technical difficulties in obtaining the reporting person's EDGAR filing codes. The reporting person's beneficial ownership has been reported under the caption "Security Ownership of Certain Beneficial Owners and Management" in the registrant's SEC filings made since February 13, 2026.
- [F2]Common stock and warrants were acquired in the Issuer's private placement disclosed in the Current Report on Form 8-K filed with the SEC on January 28, 2026.
- [F3]Reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F4]The option vests as follows: 50% on the six-month anniversary of the date of grant and the remaining shares on the twelve-month anniversary of the date of grant.
Signature
/s/ Jeff Hargroves|2026-06-08